» Articles » PMID: 32413757

Stability and Release Performance of Curcumin-loaded Liposomes with Varying Content of Hydrogenated Phospholipids

Overview
Journal Food Chem
Date 2020 May 16
PMID 32413757
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to substitute part of soybean phospholipid (SPC) with hydrogenated soybean phospholipid (HSPC) in curcumin-loaded liposomes (Cur-LP), in order to further enhance stability and release performances of curcumin. When the SPC/HSPC mass ratio changed from 10:0 to 5:5, vesicle size, encapsulation efficiency and alkali resistance of curcumin increased, although a small decrease in centrifugal stability was observed. Salt stability became worse as more HSPC was used (3:7 and 0:10). Owing storage at 4 °C and 25 °C, Cur-LP at a SPC/HSPC mass ratio of 5:5 performed well considering vesicle size, lipid oxidation and curcumin retention. These vesicles displayed also the best sustained-release performance in simulated digestion, attributed to the tighter lipid packing in membranes as indicated by fluorescence probes, DSC and FTIR. This study can guide the development of a Cur-LP product with improved shelf-life stability by using HSPC.

Citing Articles

Characterization and in vitro anticancer study of PEGylated liposome dually loaded with ferulic acid and doxorubicin.

Miatmoko A, Christy P, Isnaini A, Hariawan B, Cahyani D, Ahmad M Sci Rep. 2025; 15(1):1236.

PMID: 39775017 PMC: 11707226. DOI: 10.1038/s41598-024-82228-7.


Bifunctional Oxaliplatin (IV) Prodrug Based pH-Sensitive PEGylated Liposomes for Synergistic Anticancer Action Against Triple Negative Breast cancer.

Bhute L, Dighe S, Katari O, Yadav V, Jain S AAPS PharmSciTech. 2024; 26(1):2.

PMID: 39633214 DOI: 10.1208/s12249-024-02988-3.


Clinical Trial Findings and Drug Development Challenges for Curcumin in Infectious Disease Prevention and Treatment.

El Oirdi M, Farhan M Life (Basel). 2024; 14(9).

PMID: 39337921 PMC: 11432846. DOI: 10.3390/life14091138.


Curcumin and Baicalin Co-Loaded Nanoliposomes for Synergistic Treatment of Non-Small Cell Lung Cancer.

Su Q, Pan J, Wang C, Zhang M, Cui H, Zhao X Pharmaceutics. 2024; 16(8).

PMID: 39204318 PMC: 11359521. DOI: 10.3390/pharmaceutics16080973.


Superior Drug Delivery Performance of Multifunctional Bilosomes: Innovative Strategy to Kill Skin Cancer Cells for Nanomedicine Application.

Waglewska E, Kulbacka J, Bazylinska U Int J Nanomedicine. 2024; 19:4701-4717.

PMID: 38808148 PMC: 11131132. DOI: 10.2147/IJN.S450181.